# GFL share price today (GFL Ltd, NSE: GFLLIMITED) > GFL share price today: ₹60.02 at the NSE close on 20 November 2026, down 1.8% in a year. GFL (NSE: GFLLIMITED) is worth ₹659 crore, trades at a P/E of 8.8 and has closed between ₹39.04 and ₹62.81 over the past 52 weeks. > GFL Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. GFLLIMITED · Chemicals - Organic · data as of 20 November 2026. Page: https://www.sectoralpha.in/stocks/gfl-ltd Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms ## Key numbers - Price: ₹60.02 (−1.8% in a year) - P/E: 8.8× (higher than 88% of the last 11 years) - Revenue (Sep 2026): ₹1.0 Cr (+0.0% on a year ago) - Profit (Sep 2026), incl. one-off: ₹29.0 Cr (one-off item, see below) - Operating margin: 0.0% (−100.0 points on a year ago) - ROCE: 2%, FY26 Biggest thing to watch: the P/E is higher than 88% of its own history, so the multiple has already done part of the work. ## What is the GFL share price today? GFL Ltd's share price was ₹60.02 at the close on 20 November 2026. It has been rising for 9 weeks. That is 13.7% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹39 and ₹63, and at that close it sat 88% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 17 weeks in a row. Over the last 11 years the share price moved −4% while the NIFTY 500 moved +306%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at GFL this quarter? Three changes stood out: operating margin down 22 points on a year earlier, revenue down on a year earlier for 9 quarters in a row and highest quarterly profit in 14 quarters. 1. Operating margin down 22 points on a year earlier 39% in the September 2026 quarter, from 61%. 2. Revenue down on a year earlier for 9 quarters in a row In the September 2026 quarter revenue was ₹1 crore, 0% on a year earlier. 3. Highest quarterly profit in 14 quarters Profit of ₹29 crore in the September 2026 quarter is the highest of the last 14 quarters. ## What are GFL's latest quarterly results? For July to September 2026 (the quarter ended 30 September 2026), GFL reported revenue of ₹1.00 crore, up 0.0% from ₹1.00 crore a year earlier, and a profit of ₹29.0 crore, up 93.3% from ₹15.0 crore. ### GFL results: July to September 2026 against a year earlier | Measure | July to September 2026 | July to September 2025 | Change | | --- | --- | --- | --- | | Revenue | ₹1.00 crore | ₹1.00 crore | 0.0% | | Profit | ₹29.0 crore | ₹15.0 crore | +93.3% | | Earnings per share | ₹2.62 | ₹1.33 | +97.0% | | Operating margin | 0.0% | 100.0% | −100.0 points | The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.) ## What is the GFL share price history? GFL closed at ₹60.02 on 20 November 2026, down 1.8% from ₹61.13 a year earlier (21 November 2025) and down 21.3% over five years. Its highest weekly close since February 2016 was ₹159.86 on 7 June 2019. ### GFL share price: then and now | When | Close | Change to 20 Nov 2026 | | --- | --- | --- | | 1 week ago · 13 Nov 2026 | ₹58.79 | +2.1% | | 1 month ago · 19 Oct 2026 | ₹57.90 | +3.7% | | 6 months ago · 22 May 2026 | ₹45.79 | +31.1% | | 1 year ago · 21 Nov 2025 | ₹61.13 | −1.8% | | 3 years ago · 17 Nov 2023 | ₹98.40 | −39.0% | | 5 years ago · 18 Nov 2021 | ₹76.25 | −21.3% | | 10 years ago · 18 Nov 2016 | ₹71.77 | −16.4% | | Earliest weekly close in our records · 26 Feb 2016 | ₹62.81 | −4.4% | | Highest weekly close since February 2016 · 7 Jun 2019 | ₹159.86 | −62.5% | | Lowest weekly close since February 2016, also the 52-week low · 27 Mar 2026 | ₹39.04 | +53.7% | | 52-week high (weekly close) · 4 Sep 2026 | ₹62.81 | −4.4% | Weekly closing prices. Each change is the move from that price to the 20 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (567 weekly closes from 26 February 2016 to 20 November 2026.) ## What is the latest news on GFL? 20 Nov 2026: GFL closed at ₹60.02, up 2.1% on the week and up 3.7% on the month. Results for July to September 2026: Revenue up 0.0% and profit up 93.3% on a year earlier. ## What dividend does GFL pay? GFL has paid no dividend on the NSE since 1 April 2021, the start of the period we checked. Not in its latest year. GFL Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 5 of its last 13 reported years, so there is a history but no current dividend. (From the NSE corporate-actions record, read 20 November 2026.) ## What to watch in GFL's next results? When GFL reports October to December 2026, these are the 4 checks that show whether the story is still on course. First: Revenue against the same quarter a year earlier. - Revenue against the same quarter a year earlier. In the Sep 2026 quarter, revenue was +0.0% on a year earlier. - Whether the operating margin stays near 0.0%. It is 100.0 percentage points lower than four quarters earlier. - Profit without the one-off item. The profit in the Sep 2026 quarter was larger than the quarter's revenue, so it came from a one-off item, not the business. - Whether cash from operations catches up with profit. Only 39% of the last 3 years' profit came in as cash from operations. ## Which stock lists is GFL on? GFL is on 2 of our India lists: Momentum stocks and Penny stocks. - [Momentum stocks Market value: ₹655 crore](https://www.sectoralpha.in/momentum-stocks-india) - [Penny stocks](https://www.sectoralpha.in/penny-stocks-india) ## Is GFL profitable? GFL Ltd earned ₹29.0 Cr of net profit in the Sep 2026 quarter. That quarter includes a one-off gain bigger than its revenue, so the comparison with last year does not reflect normal business. Full-year FY26 profit was ₹45.0 Cr. Over 10 years profit has grown −22.9% a year on average. The same quarter a year earlier earned ₹15.0 Cr. The Sep 2026 quarter's profit is 2,900.0% of that quarter's revenue. 5 of the last 12 reported quarters were loss-making. Sep 2026 profit was ₹29.0 Cr, +93.3% on a year earlier. Read this profit with care: at ₹29.0 Cr it is bigger than the quarter's whole revenue of ₹1.0 Cr. No business earns more than it takes in from sales, so this is a one-off item (for example a debt settlement, a tax write-back or an asset sale), not money the business earned. The underlying business is running at a 0.0% operating margin. The jump on last year, and any P/E built on this profit, come from the one-off, not from a real turn in earnings. ## How much revenue does GFL make, and is it growing? GFL Ltd reported ₹1.0 Cr of revenue in the Sep 2026 quarter, +0.0% on the same quarter a year earlier. Over 10 years it has grown −52.6% a year on average. The last full year, FY26, came in at ₹4.0 Cr. The last four reported quarters add to ₹4.0 Cr. Recent pace: the last four quarters grew +0.0% on average, against −52.6% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +0.0%, against +0.0% a year over the last 8 quarters (stabilising). ## How much of every ₹100 of sales does GFL keep? GFL Ltd's operating margin was 0.0% in the Sep 2026 quarter, 100.0 percentage points lower than the same quarter a year ago. Across 13 years it has been between −1,200.0% and 98.6%. The latest quarter is within that range. Why the margin moved: operating margin changed −21.4 percentage points on the year while gross margin changed +0.0 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is GFL's profit turning into cash? Over the last 3 years, 39% of GFL Ltd's reported profit came in as cash from its operations, a gap worth watching. In FY26 it brought in ₹0.0 Cr of operating cash against ₹45.0 Cr of profit. After ₹0.0 Cr of estimated spending on assets (worked out from the change in fixed assets plus depreciation; no filed figure), ₹0.0 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: it spends almost nothing on new assets, so the cash goes on running the business. The next section shows the spending figures. ## Where does GFL's cash go? GFL Ltd's customer, stock and supplier day counts come out in the thousands of days on sales this small (₹4.0 Cr in FY26), so no cash-cycle chart is drawn and this section looks at its spending on assets instead. It spent ₹0.0 Cr on assets over the last 3 years. Spending on assets: ₹0.0 Cr over the last 3 years. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet. In short: almost nothing is being spent on new assets, so the cash goes on running the business. ## What is GFL's P/E ratio, and how does it compare with its own history? GFL Ltd's P/E is 8.8×, near the high end of its own history: higher than 88% of past readings. Its usual P/E (the middle reading) is 2.1×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Sep 2026 add up to ₹6.81. Where the price move came from: over 10 years the price moved −1.8% a year; about −18.5% a year came from earnings growth and about +16.7 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the GFL business getting better or worse? GFL Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. The latest quarter’s profit includes a one-off item bigger than the normal business, so the profit line is shown but does not count in this reading. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does GFL earn on its capital? GFL Ltd earned a ROCE of 2% in FY26. That is up from a low of −2% in FY21. Its return on capital used (ROIC) is left out: on sales this small it reads 8%, a number that says nothing useful about the business. It comes from a 1,125.0% net margin and 0.00× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 1,125.0% net margin × 0.00× asset turnover × 1.07× leverage (assets divided by equity) ≈ 0.0% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed. ## Does GFL have too much debt? GFL Ltd had ₹0.0 Cr of borrowings against ₹2,565 Cr of equity in FY26, so its debt is 0.00× its equity. Over 5 years borrowings went from ₹2,856 Cr to ₹0.0 Cr. Over the last 3 of those years it spent ₹0.0 Cr on assets. The spending on assets is being paid for from cash, not new debt. ## What is the GFL shareholding pattern? Domestic institutions cut their stake in GFL Ltd by 2.0 percentage points over 8 quarters, the biggest change among its owners. Domestic institutions now own 0.0% of the company. Foreign institutions moved −0.1 points over the same period, to 0.2%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Domestic institutions: −2.0 points over 8 quarters, to 0.0%; Foreign institutions: −0.1 points over 8 quarters, to 0.2%; Promoters: +0.0 points over 8 quarters, to 68.7%. Why the owners changed: domestic institutions drove it (−2.0 points). They reduced their stake. ## How far is GFL from balance-sheet trouble? For GFL Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does GFL rank in its industry? 44.9 out of 100, rank 14 of 20 in Chemicals - Organic, with 83% of the evidence available. GFL Ltd scores 44.9 out of 100 against the 20 companies it is compared with in Chemicals - Organic, ranking 14. Relative strength against the index is 11.3%, and revenue and profit growth are weak. The four parts add up to the total exactly: 16.6 + 1.6 + 11.3 + 15.4 = 44.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is GFL compared with? GFL ranks 14 of 20 Chemicals - Organic companies on the 4-Factor Sector Score, with 44.9 out of 100. 1. [Nitta Gelatin India Ltd](https://www.sectoralpha.in/stocks/nitta-gelatin-india-ltd) NITTAGELA · turning · Most evidence points up · 75% evidence 71.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.9/35 · Revenue 15% · Profit 49.4% · Operating margin change 9 points · 100% evidence Capital efficiency 21.2/25 · ROCE 27.7% (year to Mar 2026) · Operating margin 28.4% · 100% evidence Valuation 9.8/20 · P/E 12.6× · PEG n/a · 50% evidence Relative strength 12.5/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) 31.1% · 1 year n/a · 25% evidence · 4 of 12 weeks ahead Exact sum: 27.9 + 21.2 + 9.8 + 12.5 = 71.4 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Laxmi Organic Industries Ltd](https://www.sectoralpha.in/stocks/laxmi-organic-industries-ltd) LXCHEM · quiet · Most evidence points up · 85% evidence 69.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.9/35 · Revenue 21.3% · Profit 100% · Operating margin change 5 points · 100% evidence Capital efficiency 10.7/25 · ROCE 4.7% (year to Mar 2026) · Operating margin 10% · 100% evidence Valuation 18.6/20 · P/E 24.4× · PEG 0.64 · 100% evidence Relative strength 8.9/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) -2.3% · 1 year -17.4% · 25% evidence · 7 of 12 weeks ahead Exact sum: 30.9 + 10.7 + 18.6 + 8.9 = 69.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Valiant Organics Ltd](https://www.sectoralpha.in/stocks/valiant-organics-ltd) VALIANTORG · breaking out · Evidence leans up · 82% evidence 61.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.4/35 · Revenue 21.4% · Profit 100% · Operating margin change 0 points · 95% evidence Capital efficiency 8.2/25 · ROCE 5.5% (year to Mar 2026) · Operating margin 12.8% · 76% evidence Valuation 11.9/20 · P/E 13.8× · PEG n/a · 50% evidence Relative strength 17.0/20 · Strength vs its industry (price vs its 52-week average, weekly) 11.6% · Strength vs NIFTY 500 (same reading) 17.1% · 1 year 20.3% · 100% evidence · 11 of 12 weeks ahead Exact sum: 24.4 + 8.2 + 11.9 + 17 = 61.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [OCCL Ltd](https://www.sectoralpha.in/stocks/occl-ltd) OCCLLTD · losing its lead · Evidence leans up · 60% evidence 58.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 65.9% · Profit 100% · Operating margin change 3 points · 95% evidence Capital efficiency 11.6/25 · ROCE 13% (year to Mar 2026) · Operating margin 18.7% · 76% evidence Valuation 11.5/20 · P/E 7.9× · PEG n/a · 15% evidence Relative strength 12.1/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) 20% · 1 year n/a · 25% evidence · 11 of 12 weeks ahead Exact sum: 23.6 + 11.6 + 11.5 + 12.1 = 58.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Balaji Amines Ltd](https://www.sectoralpha.in/stocks/balaji-amines-ltd) BALAMINES · quiet · Evidence leans up · 82% evidence 58.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.3/35 · Revenue 20.9% · Profit 66.2% · Operating margin change 4 points · 95% evidence Capital efficiency 13.0/25 · ROCE 11% (year to Mar 2026) · Operating margin 21.8% · 76% evidence Valuation 9.5/20 · P/E 24.9× · PEG n/a · 50% evidence Relative strength 10.8/20 · Strength vs its industry (price vs its 52-week average, weekly) 8.7% · Strength vs NIFTY 500 (same reading) 13.7% · 1 year 54.4% · 100% evidence · 4 of 12 weeks ahead Exact sum: 25.3 + 13 + 9.5 + 10.8 = 58.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Shri Ahimsa Naturals Ltd](https://www.sectoralpha.in/stocks/shri-ahimsa-naturals-ltd) SHRIAHIMSA · losing its lead · Too little evidence to rank firmly · 58% evidence 58.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.0/35 · Revenue n/a · Profit n/a · Operating margin change -2 points · 27% evidence Capital efficiency 18.7/25 · ROCE 21.7% (year to Mar 2026) · Operating margin 27.5% · 100% evidence Valuation 9.7/20 · P/E 29.6× · PEG n/a · 15% evidence Relative strength 14.1/20 · Strength vs its industry (price vs its 52-week average, weekly) 13.8% · Strength vs NIFTY 500 (same reading) 19.1% · 1 year 44.8% · 100% evidence · 8 of 12 weeks ahead Exact sum: 16 + 18.7 + 9.7 + 14.1 = 58.5 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 7. [Elantas Beck India Ltd](https://www.sectoralpha.in/stocks/elantas-beck-india-ltd) ELANTAS · losing its lead · Evidence leans up · 67% evidence 56.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.6/35 · Revenue 18.7% · Profit 35.5% · Operating margin change 1 points · 95% evidence Capital efficiency 18.6/25 · ROCE 21.2% (year to Dec 2025) · Operating margin 23% · 76% evidence Valuation 7.1/20 · P/E 51.1× · PEG n/a · 50% evidence Relative strength 11.6/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) 16.7% · 1 year 29.3% · 25% evidence · 10 of 12 weeks ahead Exact sum: 19.6 + 18.6 + 7.1 + 11.6 = 56.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [BASF India Ltd](https://www.sectoralpha.in/stocks/basf-india-ltd) BASF · quiet · Evidence leans up · 75% evidence 54.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.0/35 · Revenue 15.4% · Profit 59.5% · Operating margin change -2.1 points · 100% evidence Capital efficiency 10.8/25 · ROCE 14.5% (year to Mar 2026) · Operating margin 1.9% · 100% evidence Valuation 13.7/20 · P/E 21.1× · PEG n/a · 50% evidence Relative strength 7.5/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) -21.8% · 1 year -33.9% · 25% evidence · 3 of 12 weeks ahead Exact sum: 22 + 10.8 + 13.7 + 7.5 = 54 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Fine Organic Industries Ltd](https://www.sectoralpha.in/stocks/fine-organic-industries-ltd) FINEORG · losing its lead · Evidence leans up · 100% evidence 53.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.2/35 · Revenue 12.7% · Profit 18.5% · Operating margin change 3 points · 100% evidence Capital efficiency 18.0/25 · ROCE 21.5% (year to Mar 2026) · Operating margin 25% · 100% evidence Valuation 6.7/20 · P/E 34.9× · PEG 2.54 · 100% evidence Relative strength 10.1/20 · Strength vs its industry (price vs its 52-week average, weekly) 1.5% · Strength vs NIFTY 500 (same reading) 7.9% · 1 year 20.9% · 100% evidence · 6 of 12 weeks ahead Exact sum: 18.2 + 18 + 6.7 + 10.1 = 53 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 10. [Indo Amines Ltd](https://www.sectoralpha.in/stocks/indo-amines-ltd) INDOAMIN · quiet · Evidence leans up · 75% evidence 52.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.2/35 · Revenue 22.2% · Profit 2.3% · Operating margin change -6.1 points · 100% evidence Capital efficiency 14.9/25 · ROCE 18.9% (year to Mar 2026) · Operating margin 5.5% · 100% evidence Valuation 13.5/20 · P/E 11.3× · PEG n/a · 50% evidence Relative strength 8.0/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) -7.7% · 1 year -11.1% · 25% evidence · 3 of 12 weeks ahead Exact sum: 16.2 + 14.9 + 13.5 + 8 = 52.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Fairchem Organics Ltd](https://www.sectoralpha.in/stocks/fairchem-organics-ltd) FAIRCHEMOR · losing its lead · Evidence leans up · 90% evidence 50.8 out of 100 Growth Capital Valuation Relative 12. [Jyoti Resins and Adhesives Ltd](https://www.sectoralpha.in/stocks/jyoti-resins-and-adhesives-ltd) JYOTIRES · turning · Evidence leans down · 68% evidence 49.6 out of 100 Growth Capital Valuation Relative 13. [Foseco India Ltd](https://www.sectoralpha.in/stocks/foseco-india-ltd) FOSECOIND · leader · Evidence leans down · 67% evidence 46.1 out of 100 Growth Capital Valuation Relative 14. GFL Ltd this page GFLLIMITED · breaking out · Evidence leans down · 83% evidence 44.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.6/35 · Revenue 0% · Profit 100% · Operating margin change -22 points · 100% evidence Capital efficiency 1.6/25 · ROCE 2.1% (year to Mar 2026) · Operating margin 0% · 100% evidence Valuation 11.3/20 · P/E 8.8× · PEG n/a · 15% evidence Relative strength 15.4/20 · Strength vs its industry (price vs its 52-week average, weekly) 4.8% · Strength vs NIFTY 500 (same reading) 11.3% · 1 year -1.8% · 100% evidence · 11 of 12 weeks ahead Exact sum: 16.6 + 1.6 + 11.3 + 15.4 = 44.9 · What this means: Relative strength against the index is 11.3%, and revenue and profit growth are weak. 15. [Oriental Aromatics Ltd](https://www.sectoralpha.in/stocks/oriental-aromatics-ltd) OAL · leader · Evidence leans down · 68% evidence 44.6 out of 100 Growth Capital Valuation Relative 16. [Sigachi Industries Ltd](https://www.sectoralpha.in/stocks/sigachi-industries-ltd) SIGACHI · losing its lead · Evidence leans down · 90% evidence 43.2 out of 100 Growth Capital Valuation Relative 17. [Shree Ganesh Remedies Ltd](https://www.sectoralpha.in/stocks/shree-ganesh-remedies-ltd) SGRL · breaking out · Evidence leans down · 75% evidence 36.4 out of 100 Growth Capital Valuation Relative 18. [Gem Aromatics Ltd](https://www.sectoralpha.in/stocks/gem-aromatics-ltd) GEMAROMA · basing · Too little evidence to rank firmly · 51% evidence 34.2 out of 100 Growth Capital Valuation Relative 19. [Sacheerome Ltd](https://www.sectoralpha.in/stocks/sacheerome-ltd) SACHEEROME · losing its lead · Too little evidence to rank firmly · 36% evidence 55.6 out of 100 Growth Capital Valuation Relative 20. [Citurgia Biochemicals Ltd](https://www.sectoralpha.in/stocks/citurgia-biochemicals-ltd) CITURGIA · quiet · Too little evidence to rank firmly · 25% evidence 34.3 out of 100 Growth Capital Valuation Relative Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. In this ranking every company's P/E uses its own latest official close and its last four filed quarters, the same rule as the top of this page. ROCE here is each company's last full year, as labelled, so it can differ from the four-quarter ROCE above. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Chemicals - Organic](https://www.sectoralpha.in/sectors/chemicals-organic), all 20 compared on one page. ## Which companies are close to GFL in size? GFL is the 20th largest of 20 Chemicals - Organic companies on Sector Alpha by market value (at the 20 November 2026 close). Just above it: Sacheerome, Fairchem Organics, Indo Amines, Shree Ganesh Remedies, OCCL and Gem Aromatics. It is the smallest. ### Chemicals - Organic companies close in size 1. [Sacheerome Ltd](https://www.sectoralpha.in/stocks/sacheerome-ltd) ₹847 crore 2. [Fairchem Organics Ltd](https://www.sectoralpha.in/stocks/fairchem-organics-ltd) ₹825 crore 3. [Indo Amines Ltd](https://www.sectoralpha.in/stocks/indo-amines-ltd) ₹813 crore 4. [Shree Ganesh Remedies Ltd](https://www.sectoralpha.in/stocks/shree-ganesh-remedies-ltd) ₹778 crore 5. [OCCL Ltd](https://www.sectoralpha.in/stocks/occl-ltd) ₹744 crore 6. [Gem Aromatics Ltd](https://www.sectoralpha.in/stocks/gem-aromatics-ltd) ₹724 crore 7. GFL Ltd ₹660 crore [All 20 Chemicals - Organic companies, largest first](https://www.sectoralpha.in/sectors/chemicals-organic#all-companies) ### Companies close in size in other industries 1. [Rama Steel Tubes Ltd](https://www.sectoralpha.in/stocks/rama-steel-tubes-ltd) ₹663 crore · Steel - Tubes/Pipes 2. [Influx Healthtech Ltd](https://www.sectoralpha.in/stocks/influx-healthtech-ltd) ₹660 crore · Pharma - Formulators 3. GFL Ltd ₹660 crore 4. [Kronox Lab Sciences Ltd](https://www.sectoralpha.in/stocks/kronox-lab-sciences-ltd) ₹659 crore · Speciality Chemicals 5. [Uniphos Enterprises Ltd](https://www.sectoralpha.in/stocks/uniphos-enterprises-ltd) ₹659 crore · Trading ## What else do people ask about GFL? ### What were GFL's latest quarterly results? GFL Ltd reported revenue of ₹1.0 Cr and net profit of ₹29.0 Cr for the Sep 2026 quarter. Revenue rose 0.0% and profit rose 93.3% compared with a year earlier. Earnings per share were ₹2.62. The operating margin was 0.0%, 100.0 percentage points lower than a year earlier (as of 20 November 2026). ### What is GFL's market cap? GFL Ltd's market capitalisation is ₹659 Cr at a share price of ₹60.02. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 20 November 2026). ### How is GFL performing? GFL Ltd's share price has been rising for 9 weeks. In its latest quarter, revenue rose 0.0% and profit rose 93.3% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 17 weeks running (as of 20 November 2026). ### Will GFL's share price go up? This page does not forecast GFL Ltd's share price. What it shows instead: the share price is ₹60.02, and it has been rising for 9 weeks. Its P/E of 8.8× is higher than 88% of its own last 11 years (as of 20 November 2026). ### Where is GFL in its business cycle? GFL Ltd's FY26 operating margin was 50.0%, against a 13-year range of −1,200.0% to 98.6%. The latest quarter was 0.0%, near the top of its own range. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 20 November 2026). ### What could break the GFL story? Biggest thing to watch: the P/E is higher than 88% of its own history, so the multiple has already done part of the work. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 20 November 2026). ### Is GFL a stock worth studying right now? What the numbers show: GFL Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 20 November 2026). ## Lists - Momentum stocks: https://www.sectoralpha.in/momentum-stocks-india - Penny stocks: https://www.sectoralpha.in/penny-stocks-india This is research, not advice. We’re not SEBI-registered.